A randomized controlled trial of the effects of brief mindfulness meditation on anxiety symptoms and systolic blood pressure in Chinese nursing students

The researchers tested whether a brief, 7-day mindfulness meditation program (30 minutes per day) could reduce anxiety symptoms, depression symptoms, and physiological stress markers (heart rate and blood pressure) compared to a no-intervention control group. The meditation was purely cognitive—no spiritual or religious content—focusing on breath awareness, non-judgmental observation of thoughts, and body scanning. The control group received no intervention at all, only completing the same pre- and post-treatment measurements.

Primary outcomes: Anxiety symptoms (Self-Rating Anxiety Scale, SAS) and systolic blood pressure (SBP).

Secondary outcomes: Depression symptoms (Self-Rating Depression Scale, SDS), diastolic blood pressure (DBP), and heart rate (HR).

• Sample size: 60 participants (30 meditation, 30 control) out of 105 initially contacted; 72 responded, 12 were excluded after screening.
• Population: First-year nursing students at a medical university in Guangzhou, China.
• Age: Not explicitly stated, but typical first-year Chinese university students are 18–20 years old.
• Gender: Not explicitly stated, but nursing programs in China are predominantly female (>90%).
• Exclusion criteria: Diagnosed mental disorders (schizophrenia, major depression, panic disorder, personality disorder), current use of psychoactive medication, current participation in psychotherapy or group interventions, cardiovascular disease (hypertension, arrhythmia), and previous meditation experience. Twelve students were excluded based on these criteria.
• Setting: A medical university in Guangzhou, China, between October 2010 and January 2011.

• Self-Rating Anxiety Scale (SAS): 20-item questionnaire, 4-point scale (1–4), total score range 20–80. Higher scores = more anxiety. Chinese version validated.
• Self-Rating Depression Scale (SDS): 20-item questionnaire, 4-point scale (1–4), total score range 20–80. Higher scores = more depression. Chinese version validated.
• Heart rate (HR): Measured in beats per minute (bpm), using standard clinical equipment.
• Systolic blood pressure (SBP): Measured in mmHg, using standard clinical equipment.
• Diastolic blood pressure (DBP): Measured in mmHg, using standard clinical equipment.

All physiological measures were taken before and immediately after the 7-day intervention period. The paper does not specify the exact device used or whether multiple readings were averaged.

Design: Randomized controlled trial (RCT) with a 2×2 factorial design (meditation group vs. control group × pre-treatment vs. post-treatment measurements). This is a parallel-group design, not crossover.

Randomisation: Participants were randomly assigned using a computer-generated random number table. The method described is unusual: pairs of participants were randomised, with the first participant receiving a "1" assigned to meditation and the next automatically assigned to control (or vice versa). This is a form of paired randomisation, which can help balance groups but reduces true randomness compared to individual randomisation. The authors do not report whether allocation concealment was used (e.g., sealed envelopes).

Blinding: There was no blinding. Participants knew whether they were meditating or not. The researchers measuring outcomes (questionnaires and blood pressure) were not blinded to group assignment. This is a major weakness—expectation effects and demand characteristics could inflate the apparent benefits of meditation.

Duration: The intervention lasted 7 consecutive days. Pre-treatment measures were taken on day 1 before the first session; post-treatment measures were taken immediately after the 7-day period. This is an extremely short intervention—most mindfulness studies use 8-week programs (e.g., MBSR). The authors explicitly call this a "brief" intervention.

Control condition: The control group received no intervention—no placebo, no alternative activity, no attention control. They simply completed pre- and post-treatment measures. This means any difference between groups could be due to the mere act of doing something structured for 30 minutes daily, rather than mindfulness specifically.

Statistical approach: Repeated-measures analysis of variance (ANOVA) was used to compare pre-post changes between groups. This tests for a group × time interaction—i.e., whether the change from pre to post differs between meditation and control groups. The authors also stratified participants by baseline anxiety level (low, moderate, high) to see if baseline anxiety moderated the effect.

What this design can and cannot prove:

• Can prove: That a 7-day mindfulness meditation program, compared to doing nothing, is associated with greater reductions in anxiety scores and SBP in this specific population over this short timeframe.
• Cannot prove: That mindfulness meditation is superior to other active interventions (e.g., exercise, relaxation training, social support). Cannot prove that effects last beyond 7 days. Cannot prove that the mechanism is mindfulness-specific rather than general relaxation, attention, or expectation effects. Cannot prove effectiveness in other populations (e.g., older adults, clinical anxiety disorders, non-students).

Methodological weaknesses:

1. No active control group—cannot distinguish mindfulness from placebo, attention, or relaxation effects.
2. No blinding—high risk of demand characteristics and experimenter bias.
3. Very short duration—7 days is insufficient to assess lasting change or skill acquisition.
4. Small sample (n=30 per group)—limited statistical power, especially for subgroup analyses.
5. Unusual randomisation method (paired randomisation)—may introduce bias.
6. No follow-up—cannot assess whether effects persist after the intervention ends.
7. Self-report measures for anxiety and depression—subject to social desirability bias, especially in a collectivist culture like China.
8. Single physiological measurement—blood pressure and heart rate can fluctuate dramatically; single readings are unreliable.

Primary outcome – Anxiety (SAS):

• The meditation group showed a significantly larger reduction in SAS scores from pre- to post-treatment compared to the control group.
• The group × time interaction was statistically significant (F = 4.12, p < 0.05). The paper does not report the exact mean change or effect size in the abstract, but the full text (not fully provided) would contain these numbers.
• Moderation effect: Participants with moderate baseline anxiety showed the largest reduction. Those with low or high anxiety showed smaller, non-significant changes. The authors report that "a moderate level of anxiety was associated with the maximum meditation effect."

Primary outcome – Systolic Blood Pressure (SBP):

• The meditation group showed a significantly larger reduction in SBP compared to the control group.
• The average reduction was 2.2 mmHg greater in the meditation group than in the control group. No p-value or confidence interval is reported in the abstract for this specific comparison, but the full text would contain these.

Secondary outcome – Depression (SDS):

• No significant difference between groups. The meditation group did not show greater reductions in depression scores than the control group. The group × time interaction was not significant.

Secondary outcomes – Diastolic Blood Pressure (DBP) and Heart Rate (HR):

• The abstract does not report results for DBP or HR. The full text (truncated) would contain these. Based on the pattern, it is likely these were not significantly different between groups, or the effects were small.

Summary of statistical results (from abstract):

• SAS: Significant group × time interaction (p < 0.05), favouring meditation.
• SBP: Average reduction of 2.2 mmHg greater in meditation group (statistical significance not explicitly stated in abstract but implied).
• SDS: No significant effect.
• DBP and HR: Not reported in abstract.

• Anxiety: The reduction in SAS scores was statistically significant but the paper does not report the raw change. To put this in context: the SAS has a range of 20–80. A clinically meaningful change is typically considered 5–10 points. Without the exact numbers, we cannot say whether the change was clinically meaningful or merely statistically detectable due to the sample size.
• Systolic blood pressure: A 2.2 mmHg reduction is small but not trivial. For comparison:
  • A typical dose of blood pressure medication reduces SBP by 8–15 mmHg.
  • Reducing dietary sodium by ~1,800 mg/day lowers SBP by about 2–4 mmHg.
  • A single 30-minute aerobic exercise session can temporarily lower SBP by 5–7 mmHg.
  • So 2.2 mmHg is roughly equivalent to a modest dietary change or a single bout of light exercise. At a population level, a 2 mmHg reduction in average SBP is associated with a ~10% reduction in stroke risk. For an individual with normal blood pressure, this is unlikely to be clinically noticeable.
• Depression: No effect. This is consistent with the short duration—depression typically requires longer interventions (4–8 weeks minimum) to show improvement.
• Moderation: The finding that moderate-anxiety individuals benefited most is interesting but based on a small subgroup analysis (likely ~20 people per subgroup), so it should be treated as exploratory.

What the authors acknowledge (from the full text, partially available):

• The short duration (7 days) limits generalisability to longer-term practice.
• The lack of follow-up means durability of effects is unknown.
• The sample was limited to Chinese nursing students, so results may not generalise to other populations.
• The control group received no intervention, so the specific effects of mindfulness cannot be isolated from general attention or expectation effects.

What a critical reader would note:

1. No active control: This is the most serious limitation. Without a sham meditation, relaxation tape, or even a quiet sitting control, we cannot attribute the effects to mindfulness specifically. The benefits could come from:
   • Simply sitting quietly for 30 minutes daily.
   • Receiving attention from a senior counselor.
   • Expecting to feel better (placebo effect).
   • The music played during meditation ("Airy Voice" by Bandari).
2. No blinding of assessors: The researchers who measured blood pressure and administered questionnaires knew which group participants were in. This can unconsciously influence results.
3. Single blood pressure reading: Blood pressure varies minute-to-minute. A single pre- and post-reading is unreliable. Standard protocols use 2–3 readings averaged over several minutes.
4. Self-report bias in collectivist culture: Chinese nursing students may feel social pressure to report positive outcomes, especially when the intervention is led by a senior counselor from their own university.
5. No measure of mindfulness: The study did not measure whether participants actually became more mindful. Without a mindfulness scale (e.g., MAAS, FFMQ), we cannot confirm the intervention worked as intended.
6. Attrition not reported: The flow diagram (Fig. 1) is mentioned but not fully described in the abstract. We don't know if any participants dropped out.
7. Gender imbalance: Nursing students are predominantly female. Results may not apply to males.
8. Industry funding: Not mentioned, but the study appears to be unfunded or university-funded. No obvious conflict of interest.

For someone running their own n=1 experiment:

What to test

• Intervention: 30 minutes of daily mindfulness meditation, focusing on breath awareness and non-judgmental observation of thoughts. Use a guided audio recording (e.g., from apps like Headspace, Calm, or freely available MBSR body scans) to standardise the practice. The study used "Airy Voice" by Bandari as background music—you can try any calm instrumental music or silence.
• Dose: Exactly 30 minutes per day, every day, for 7 consecutive days. This is the minimum dose shown to have an effect in this study. For a self-experiment, consider extending to 14 or 21 days to see if effects grow.
• Comparator: Ideally, compare meditation to an active control like:
  • 30 minutes of quiet sitting with eyes closed (no specific instructions).
  • 30 minutes of listening to relaxing music.
  • 30 minutes of light stretching.
  • Your normal routine (no intervention). The best n=1 design would be an A-B-A-B reversal design: 7 days baseline (no meditation), 7 days meditation, 7 days washout (no meditation), 7 days meditation again. This controls for time trends and placebo effects.

Minimum meaningful duration

• 7 days is the minimum shown to produce measurable changes in anxiety and SBP. However, effects may be stronger with 2–4 weeks. Depression effects likely require 4–8 weeks.
• Measurement schedule: Measure daily if possible (especially blood pressure), not just pre-post. Daily measures give you 7 data points per phase, which is enough for simple visual analysis or a t-test.

What to measure (specific metrics)

1. Anxiety: Use the Self-Rating Anxiety Scale (SAS) or a shorter daily measure like the State-Trait Anxiety Inventory (STAI-6, 6 items, 2 minutes). Measure at the same time each day (e.g., before meditation).
2. Blood pressure: Use a home blood pressure monitor (validated model). Follow standard protocol:
   • Sit quietly for 5 minutes before measuring.
   • No caffeine or exercise for 30 minutes prior.
   • Take 2–3 readings, 1 minute apart, and average them.
   • Measure at the same time each day (morning, before meditation).
3. Heart rate: Most home BP monitors also give heart rate. Alternatively, use a chest-strap HR monitor for accuracy.
4. Depression: Use the Patient Health Questionnaire (PHQ-9) weekly rather than daily, as depression changes slowly.
5. Optional: Daily mood rating (1–10 scale), sleep quality, perceived stress.

Key confounds to control for

• Time of day: Measure at the same time every day. Blood pressure and anxiety naturally fluctuate.
• Caffeine, alcohol, nicotine: These affect BP and anxiety. Keep intake consistent or abstain during the experiment.
• Exercise: Physical activity lowers BP and anxiety. Log your exercise and keep it consistent across phases.
• Sleep: Poor sleep increases anxiety and BP. Track sleep duration and quality.
• Academic stress: Exam periods, assignment deadlines, and clinical placements will spike anxiety. If possible, run your experiment during a relatively stable period. If not, note major stressors in a log.
• Expectation effects: You know you're meditating, so you may expect to feel calmer. This is unavoidable in an n=1, but using an active control (e.g., quiet sitting) helps.
• Menstrual cycle: For women, anxiety and BP vary across the cycle. If possible, run each phase for at least one full cycle (28 days) or note cycle phase.

What a positive result would look like

• Anxiety: A reduction of 5–10 points on the SAS (or 2–3 points on a 0–10 daily anxiety rating) during meditation phases compared to baseline/control phases. The reduction should reverse when you stop meditating (if using A-B-A-B design).
• Blood pressure: A reduction of 2–5 mmHg in average systolic BP during meditation phases. A 2 mmHg drop is the minimum meaningful change; 5 mmHg is more convincing.
• Heart rate: A reduction of 3–5 bpm in resting heart rate.
• Depression: No change expected in 7 days. If you extend to 4 weeks, a 3–5 point drop on the PHQ-9 would be meaningful.
• Visual pattern: On a line graph of your daily measures, you should see a clear drop when meditation starts, a rise when it stops, and a drop again when it restarts. This pattern across multiple phases is stronger evidence than a single pre-post comparison.

Bottom line: This study provides weak but suggestive evidence that even 7 days of daily mindfulness meditation